Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

Abstract Background The reporting of adverse drug reactions (ADR) by patients represents an interesting challenge in the field of pharmacovigilance, but the reporting system is not adequately implemented in France. In 2015, only 20 MS patients in France reported ADR due to first-line disease-modifyi...

全面介绍

书目详细资料
Main Authors: Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, François Montastruc, Damien Chevanne, Jean-Jacques Parienti, Laure Peyro-Saint-Paul
格式: 文件
语言:English
出版: BMC 2018-03-01
丛编:Trials
主题:
Pharmacovigilance
E-health
Patient reporting
Multiple sclerosis
Adverse drug reaction
Mobile application
在线阅读:http://link.springer.com/article/10.1186/s13063-018-2560-4

因特网

http://link.springer.com/article/10.1186/s13063-018-2560-4

相似书籍